Therapy group:BMT preconditioning regimen for transfusion-dependent thalassemia

2 trials

Sponsors

The 923rd Hospital of the Joint Logistics Support Force of the People's Liberation Army

Conditions

transfusion-dependent thalassemia

Early Phase 1

Exploration of BMT preconditioning transplantation in the treatment of transfusion-dependent thalassemia

RecruitingChiCTR2300071890

The 923rd Hospital of the Joint Logistics Support Force of the People's Liberation Armytransfusion-dependent thalassemia

Start: 2023-06-01Updated: 2023-06-12

Unknown Phase

A multicenter clinical study of BMT preconditioning transplantation in the treatment of transfusion-dependent thalassemia

RecruitingChiCTR2300077054

The 923rd Hospital of the Joint Logistics Support Force of the People's Liberation Armytransfusion-dependent thalassemia

Start: 2023-11-01Updated: 2023-10-30

Related Papers

Fludarabine, Busulfan, Thiotepa, and Melphalan: A Novel Low-Toxicity Myeloablative Conditioning Regimen for Haploidentical HSCT in Children and Adolescents Aged ≥7 Years With Transfusion-Dependent β-Thalassemia.

2026-07-23

A novel reduce toxity myeloablative conditioning regimen f-BMT improves efficacy and safety of allogeneic hematopoietic stem cell transplantation in patients with transfusion-dependent thalassemia: A multicenter clinical trial

Blood2025-11-03